Ryuvidine was shown to cause cell death in a panel of cancer cell lines [38] and this cytotoxic activity is also present in cell lines, such as HeLa cells that lack a functional Rb pathway, suggesting that the main mechanism of action of Ryuvidine may not be related to CDK4 inhibition. Here, RB1 is linked to cancer.